# Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota

**Authors:** Hoang Do, Esther Asiamah, Mayanijesu Olorife, Arathi Pillai, Sakshi Patel, Ponniah Selvakumar, Sidhartha D. Ray, Ashakumary Lakshmikuttyamma

PMC · DOI: 10.18632/oncotarget.28779 · Oncotarget · 2025-11-14

## TL;DR

This review explores how bifidobacterium, a gut microbe, may help fight cancer through multiple mechanisms like boosting treatments and detoxifying harmful substances.

## Contribution

The paper provides a comprehensive overview of bifidobacterium's anticancer mechanisms and its interactions with diet and therapies.

## Key findings

- Bifidobacterium can enhance chemotherapy, immunotherapy, and radiation therapy effectiveness.
- It modulates immune pathways and promotes apoptosis through regulation of signaling molecules.
- Diet influences bifidobacterium's presence in the gut, affecting its anticancer potential.

## Abstract

Bifidobacterium has captured major attention recently because of its health benefits and extensive research highlighting its potential in cancer treatment and prevention. Evidence suggests that bifidobacterium can actively fight against various types of cancer, including those of the colon, lungs, breast, and stomach. Research indicates that several species of bifidobacterium can potentiate the action of chemotherapy, immunotherapy and radiation therapy in battling tumors, and reducing their adverse effects. Bifidobacteria shows its multipronged effect by modulating various immunomodulatory and inflammatory signaling pathways, potentially leading to the suppression of tumor growth. Moreover, different species of bifidobacteria are known to regulate signaling molecules involved in promoting apoptosis. In addition, bifidobacteria have an impact on the regulation of diverse microRNAs. The anticancer properties of bifidobacterium may also stem from its ability to detoxify carcinogens and transform dietary elements. This review also covers how dietary factors can influence the prevalence of bifidobacterium in the gut, further affecting its anticancer capabilities.

## Linked entities

- **Diseases:** colon cancer (MONDO:0002032), lung cancer (MONDO:0005138), breast cancer (MONDO:0004989), stomach cancer (MONDO:0001056)
- **Species:** Bifidobacterium (taxon 1678)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), carcinogens (MESH:D011230), inflammatory (MESH:D007249)
- **Species:** Bifidobacterium (genus) [taxon 1678]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12758158/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12758158/full.md

## References

121 references — full list in the complete paper: https://tomesphere.com/paper/PMC12758158/full.md

---
Source: https://tomesphere.com/paper/PMC12758158